These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21307076)

  • 61. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
    Bresson D; Togher L; Rodrigo E; Chen Y; Bluestone JA; Herold KC; von Herrath M
    J Clin Invest; 2006 May; 116(5):1371-81. PubMed ID: 16628253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
    Mooradian AD; Albert SG; Bernbaum M; Plummer S
    Diabetes Care; 1996 Aug; 19(8):883-4. PubMed ID: 8842609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral insulin and the induction of tolerance in man: reality or fantasy?
    Pozzilli P; Gisella Cavallo M
    Diabetes Metab Res Rev; 2000; 16(5):306-7. PubMed ID: 11025554
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
    J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes.
    Ergun-Longmire B; Marker J; Zeidler A; Rapaport R; Raskin P; Bode B; Schatz D; Vargas A; Rogers D; Schwartz S; Malone J; Krischer J; Maclaren NK
    Ann N Y Acad Sci; 2004 Dec; 1029():260-77. PubMed ID: 15681764
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
    Faustman DL; Wang L; Okubo Y; Burger D; Ban L; Man G; Zheng H; Schoenfeld D; Pompei R; Avruch J; Nathan DM
    PLoS One; 2012; 7(8):e41756. PubMed ID: 22905105
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes.
    Ryhänen SJ; Härkönen T; Siljander H; Näntö-Salonen K; Simell T; Hyöty H; Ilonen J; Veijola R; Simell O; Knip M
    Diabetes Care; 2011 Jun; 34(6):1383-8. PubMed ID: 21515841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
    Alhadj Ali M; Liu YF; Arif S; Tatovic D; Shariff H; Gibson VB; Yusuf N; Baptista R; Eichmann M; Petrov N; Heck S; Yang JHM; Tree TIM; Pujol-Autonell I; Yeo L; Baumard L; Stenson R; Howell A; Clark A; Boult Z; Powrie J; Adams L; Wong FS; Luzio S; Dunseath G; Green K; O'Keefe A; Bayly G; Thorogood N; Andrews R; Leech N; Joseph F; Nair S; Seal S; Cheung H; Beam C; Hills R; Peakman M; Dayan CM
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluating T cell responses prior to the onset of type 1 diabetes.
    Arif S; Yusuf N; Domingo-Vila C; Liu YF; Bingley PJ; Peakman M
    Diabet Med; 2022 Sep; 39(9):e14860. PubMed ID: 35477909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mucosal exposure to antigen: cause or cure of type 1 diabetes?
    Fousteri G; von Herrath M; Bresson D
    Curr Diab Rep; 2007 Apr; 7(2):91-8. PubMed ID: 17425912
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes.
    Liu YF; Powrie J; Arif S; Yang JHM; Williams E; Khatri L; Joshi M; Lhuillier L; Fountoulakis N; Smith E; Beam C; Lorenc A; Peakman M; Tree T
    Diabetes; 2022 Apr; 71(4):722-732. PubMed ID: 35073398
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
    Sims EK; Bundy BN; Stier K; Serti E; Lim N; Long SA; Geyer SM; Moran A; Greenbaum CJ; Evans-Molina C; Herold KC;
    Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658358
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proposal for generating new beta cells in a muted immune environment for type 1 diabetes.
    Levetan C; Pozzilli P; Jovanovic L; Schatz D
    Diabetes Metab Res Rev; 2013 Nov; 29(8):604-6. PubMed ID: 23853103
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.
    Ziegler AG; Danne T; Daniel C; Bonifacio E
    Med; 2021 Oct; 2(10):1120-1137. PubMed ID: 34993499
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Actual strategies for preventing type-1 diabetes: international literature review].
    Grechushkina NA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Oct; 31(Special Issue 2):1189-1196. PubMed ID: 38069884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type 1 diabetes - What's new in prevention and therapeutic strategies?
    Pilśniak A; Otto-Buczkowska E
    Pediatr Endocrinol Diabetes Metab; 2023; 29(3):196-201. PubMed ID: 38031834
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment.
    Collison A; Mattes J; Plank M; Foster PS
    J Allergy Clin Immunol; 2011 Jul; 128(1):160-167.e4. PubMed ID: 21571357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin.
    Nagyeri G; Radacs M; Ghassemi-Nejad S; Tryniszewska B; Olasz K; Hutas G; Gyorfy Z; Hascall VC; Glant TT; Mikecz K
    J Biol Chem; 2011 Jul; 286(26):23559-69. PubMed ID: 21566135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.